319-60-8

Basic information

• Product Name: 3,5-DIFLUORO-4-METHOXYBENZOIC ACID
• Synonyms: 3,5-DIFLUORO-4-METHOXYBENZOIC ACID;3,5-difluoro-4-methoxybenbenzoic acid;3,5-Difluoro-4-methoxybenzoic acid 99%;4-Carboxy-2,6-difluoroanisole;4-Carboxy-2,6-difluoroanisole, 3,5-Difluoro-p-anisic acid;3,5-Difluoro-4-methoxybenzoicacid99%
• CAS NO: 319-60-8
• Molecular Formula: C₈H₆F₂O₃
• Molecular Weight: 188.13
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Fluorine series
• Mol File: 319-60-8.mol
• Article Data: 4

Chemical Properties

• Melting Point: 164-166°C
• Boiling Point: 286℃
• Flash Point: 127℃
• Appearance: /
• Density: 1.399
• Vapor Pressure: 0.00123mmHg at 25°C
• Refractive Index: 1.504
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 3.79±0.10(Predicted)
• CAS DataBase Reference: 3,5-DIFLUORO-4-METHOXYBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-DIFLUORO-4-METHOXYBENZOIC ACID(319-60-8)
• EPA Substance Registry System: 3,5-DIFLUORO-4-METHOXYBENZOIC ACID(319-60-8)

Safety Data

• Hazard Codes: Xi,T
• Statements: 25-36/37/38
• Safety Statements: 45-37-26
• Hazardous Substances Data: 319-60-8(Hazardous Substances Data)

Usage

General Description

3,5-Difluoro-4-methoxybenzoic acid is a chemical compound containing a benzene ring with two fluorine atoms and a methoxy group attached to it. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 3,5-Difluoro-4-methoxybenzoic acid is also known for its antimicrobial and anti-inflammatory properties, making it a potential candidate for drug development. Additionally, it is used as a building block in organic synthesis and has the potential for various applications in the fields of medicine and agriculture.

InChI:InChI=1/C8H6F2O3/c1-13-7-5(9)2-4(8(11)12)3-6(7)10/h2-3H,1H3,(H,11,12)

Upstream product

• 178374-78-2 3',5'-difluoro-4'-hydroxypropiophenone 
• 67-56-1 methanol 
• 124-41-4 sodium methylate 
• 121602-93-5 3,4,5-trifluorobenzoic acid 
• 329-45-3 Methyl 3,5-difluoro-4-methoxybenzoate 
• 71292-82-5 3,5-difluoro-4-methoxy-propiophenone 

Downstream Products

• 343-79-3 3,5-difluoro-4-methoxy-benzoic acid amide 
• 397-63-7 4-((Z)-3,5-difluoro-4-methoxy-benzylidene)-2-phenyl-4H-oxazol-5-one 
• 455-55-0 3,5-difluoro-4-methoxybenzohydrazide 
• 1285575-02-1 3-(3,5-difluoro-4-methoxybenzoyl)-2,3-dihydro-1,1-dioxo-1,3-benzothiazole 
• 1285575-01-0 3-(3,5-difluoro-4-methoxybenzoyl)-2,3-dihydro-1,3-benzothiazole 
• 1285572-87-3 3-(3,5-difluoro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1257265-62-5 (2R,4S)-5-biphenyl-4-yl-4-(3,5-difluoro-4-methoxybenzoylamino)-2-methylpentanoic acid ethyl ester 
• 1257265-63-6 (2R,4S)-5-biphenyl-4-yl-4-(3,5-difluoro-4-hydroxybenzoylamino)-2-methylpentanoic acid ethyl ester 
• 1257265-61-4 (2R,4S)-5-biphenyl-4-yl-4-(3,5-difluoro-4-hydroxybenzoylamino)-2-methylpentanoic acid 
• 501701-43-5 3,5-difluoro-4-methoxybenzoyl chloride 
• 706786-41-6 (3,5-difluoro-4-methoxy-phenyl)-methanol 
• 400-84-0 4-(3,5-difluoro-4-methoxy-phenoxy)-3,5-diiodo-aniline; hydrochloride 
• 348-92-5 5-(2,6-diiodo-4-nitro-phenoxy)-1,3-difluoro-2-methoxy-benzene 
• 363-48-4 4-nitro-benzoic acid-(3,5-difluoro-4-methoxy-anilide) 

Relevant articles and documents

PLANT DISEASE CONTROL AGENT, AND PLANT DISEASE CONTROL METHOD

Disclosed is a plant disease control agent comprising an amide compound represented by the formula (1) as an active ingredient. (1): wherein X1 represents a fluorine atom or a methoxy group; X2 represents a hydrogen atom, a halogen atom, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C1-C4 haloalkyl group, a C1-C4 alkoxy group, a C1-C4 alkylthio group, a C1-C4 hydroxyalkyl group and so on; Z1 represents an oxygen atom or a sulfur atom; A1 represents a single bond, -CH2- and so on; and G1 represents a group CR6R7R8, a C3-6 cycloalkyl group and so on.

METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES

The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for